Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9...(nts filed with the SEC (htt This press...)

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(AUDITED)

Item Fiscal Years Ended December 31,

2007 2006

Net sales $ 9,129,779 $ 2,506,715

Cost of sales 8,603,795 2,326,419

Gross profit 525,984 180,296

Operating expenses

Consulting and professional fees 794,324 822,529

Officers' compensation 285,941 89,528

'/>"/>